Financhill
Back

Portage Biotech Quote, Financials, Valuation and Earnings

Portage Biotech Price Quote

$3.17
+0.17 (+-17.02%)
(Updated: December 14, 2024 at 5:48 AM ET)

Portage Biotech Key Stats

Sell
16
Portage Biotech (PRTG) is a Sell

Day range:
$2.95 - $3.55
52-week range:
$2.10 - $40.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.06%

Volume:
34.3K
Avg. volume:
31.4K
1-year change:
-87.4%
Market cap:
$4.3M
Revenue:
$0
EPS:
$-94.66

How Much Does Portage Biotech Make?

Data Unavailable

Is Portage Biotech Growing As A Company?

Data Unavailable

Portage Biotech Stock Price Performance

  • Did Portage Biotech Stock Go Up Last Month?
    Portage Biotech share price went down by -28.91% last month
  • Did PRTG's Share Price Rise Over The Last Year?
    PRTG share price fell by -87.4% over the past 1 year

What Is Portage Biotech 52-Week High & Low?

Portage Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Portage Biotech?

  • How Much Debt Does Portage Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Portage Biotech Have?
    Cash and short term investments quarterly total is $1.8M
  • What Is Portage Biotech’s Book Value Per Share?
    Book value per share is 1.25

Is Portage Biotech Cash Flow Positive?

  • What Is PRTG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.8M
  • What Is Portage Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.3M
  • What Is Portage Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Portage Biotech Return On Invested Capital

Data Unavailable

Portage Biotech Earnings Date & Stock Price

Portage Biotech Competitors

  • Who Are Portage Biotech's Competitors?
    Below is a list of companies who compete with Portage Biotech or are related in some way:
    • Applied Therapeutics Inc (APLT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Portage Biotech Dividend Yield

Portage Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 140.00
Upside from Last Price: 4566.67%

Major Shareholders

  • How many PRTG shares are owned by institutional investors?
    128K PRTG shares are owned by institutional investors
  • How many PRTG shares are owned by insiders?
    0 PRTG shares are owned by insiders